Link Pharma Chem (BOM:524748) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Link Pharma Chem LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Link Pharma Chem's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.00.

Link Pharma Chem's long-term debt to total assets ratio stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Link Pharma Chem LT-Debt-to-Total-Asset Historical Data

The historical data trend for Link Pharma Chem's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Link Pharma Chem LT-Debt-to-Total-Asset Chart

Link Pharma Chem Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.10

0.17

0.12

0.10

0.06

Link Pharma Chem Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	0.06	-	0.05	-

Link Pharma Chem LT-Debt-to-Total-Asset Calculation

Link Pharma Chem's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )	/	Total Assets (A: Mar. 2023 )
	=	19.801	/	324.58
	=	0.06

Link Pharma Chem's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0	/	0
	=

Link Pharma Chem (BOM:524748) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Link Pharma Chem LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Link Pharma Chem's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Link Pharma Chem (BOM:524748) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Link Pharma Chem Ltd (BOM:524748) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

161 - 162, GIDC Estate, Nandesari Industrial Estate, Nandesari, Vadodara, GJ, IND, 391340

Website

https://www.linkpharmachem.co.in

Link Pharma Chem Ltd is a chemical manufacturing company in India. The company is engaged in the manufacturing and exporting of multi-range intermediates for pharmaceuticals, agro-industries, and specialty chemicals. It is also engaged in custom synthesis/contract manufacturing for multistage synthesis for a range of companies. It operates through one single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.

Link Pharma Chem (BOM:524748) Headlines

No Headlines